Canada Breast Cancer Diagnostics and Therapeutics Market Share, Analysis, Trends and Forecast 2025

Canada breast cancer diagnostics and therapeutics market are estimated to grow significantly at a CAGR of 9.1% during the forecast period. The factors that influence the market growth in Canada include increasing the screening test for breast cancer and prevalence due to changes in life style. Breast cancer is the second leading cause of mortality in Canada. The incidence rate of breast cancer in Canada slightly increases with the increase in years. According to the Canadian Cancer Society about 26,300 women diagnosed with breast cancer in 2017. This accounts for 25% of all new cancer cases in women. The mortality due to breast cancer was about 5,000, which is 13% of all cancer mortality in women. On average 72 women in Canada were diagnosed and 14 women died with breast cancer every day. The breast cancer also happened in men about 230 men were diagnosed and mortality about 60 from breast cancer in 2017.

Get Sample Copy of Canada Breast Cancer Diagnostics and Therapeutics Market at: https://www.omrglobal.com/request-sample/canada-breast-cancer-diagnostics-therapeutics-market

The companies which are contributing to the growth of the Canada breast cancer diagnostics and therapeutics market include, AbbVie Inc., Astellas Pharma Inc., Bristol-Myers Squibb Co., Eli Lilly and Co., Hologic Inc., Halozyme, Inc., Johnson & Johnson Services Inc., Merck & Co., Inc., Pfizer Inc. And others.

Canada breast cancer diagnosis and therapeutics market are segmented on the basis of cancer type, diagnostics, and therapeutics. In cancer type segment market is further classified into ductal carcinoma in-situ (DCIS), invasive ductal carcinoma (IDC), triple negative breast cancer (TNBC), inflammatory breast cancer and others. In diagnostics technology, the segment market is further classified into mammography, biopsy, position emission tomography/Computed tomography, ultrasound, and others. The therapeutics technology segment market is further segregated into chemotherapy, hormone therapy, targeted therapy, and others.

For More Information, get A full report of Canada Breast Cancer Diagnostics and Therapeutics Market is available at: https://www.omrglobal.com/industry-reports/canada-breast-cancer-diagnostics-therapeutics-market

The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market.
Market Segmentation

Breast Cancer Diagnostics and Therapeutics Market by Cancer Type

o Ductal Carcinoma In-Situ (DCIS)
o Invasive Ductal Carcinoma (IDC)
o Triple Negative Breast Cancer (TNBC)
o Inflammatory Breast Cancer
o Others (Invasive lobular carcinoma)

Breast Cancer Diagnostics and Therapeutics Market by Diagnostics

o Mammography
o Biopsy
o PET/CET
o Ultrasound
o Others (MRI)

Breast Cancer Diagnostics and Therapeutics Market by Therapeutics

o Chemotherapy
o Hormone Therapy
o Targeted Therapy
o Others (Radiation Therapy, Surgery)

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/canada-breast-cancer-diagnostics-therapeutics-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.